Results 1 to 10 of about 28,974 (147)

Synergistic Inhibition of Protein Fibrillation by Proline and Sorbitol: Biophysical Investigations. [PDF]

open access: yesPLoS ONE, 2016
We report here interesting synergistic effects of proline and sorbitol, two well-known chemical chaperones, in the inhibition of fibrillation of two proteins, insulin and lysozyme.
Sinjan Choudhary   +3 more
doaj   +5 more sources

Apomorphine Targets the Pleiotropic Bacterial Regulator Hfq

open access: yesAntibiotics, 2021
Hfq is a bacterial regulator with key roles in gene expression. The protein notably regulates translation efficiency and RNA decay in Gram-negative bacteria, thanks to its binding to small regulatory noncoding RNAs. This property is of primary importance
Florian Turbant   +6 more
doaj   +1 more source

Protein Fibrillation Lag Times During Kinetic Inhibition [PDF]

open access: yesBiophysical Journal, 2014
Protein aggregation is linked to more than 30 human pathologies, including Alzheimer's and Parkinson's diseases. Since small oligomers that form at the beginning of the fibrillation process probably are the most toxic elements, therapeutic strategies involving fibril fragmentation could be detrimental. An alternative approach, named kinetic inhibition,
Pagano, Rodrigo Sebastián   +7 more
openaire   +3 more sources

Unraveling the Interaction of a Neurological Drug Rivastigmine with Human Insulin Protein: A Biophysical Method in Combination with Molecular Docking and Molecular Dynamics Simulation

open access: yesJournal of Disability Research, 2023
The study aims to examine the aggregation of proteins due to their association with various conformational problems including well-known neurodegenerative diseases like Alzheimer’s disease, Parkinson’s disease, and Huntington’s disease.
Nada H. Aljarba   +3 more
doaj   +1 more source

Inhibiting transthyretin amyloid fibril formation via protein stabilization [PDF]

open access: yesProceedings of the National Academy of Sciences, 1996
Transthyretin (TTR) amyloid fibril formation is observed systemically in familial amyloid polyneuropathy and senile systemic amyloidosis and appears to be the causative agent in these diseases. Herein, we demonstrate conclusively that thyroxine (10.8 μM) inhibits TTR fibril formation efficiently in vitro and ...
G J, Miroy   +5 more
openaire   +2 more sources

Pyrroloquinoline quinone inhibits the fibrillation of amyloid proteins [PDF]

open access: yesPrion, 2010
Several neurodegenerative diseases involve the selective damage of neuron cells resulting from the accumulation of amyloid fibril formation. Considering that the formation of amyloid fibrils as well as their precursor oligomers is cytotoxic, the agents that prevent the formation of oligomers and/or fibrils might allow the development of a novel ...
Jihoon, Kim   +10 more
openaire   +2 more sources

Amyloid Cross-Seeding: Mechanism, Implication, and Inhibition

open access: yesMolecules, 2022
Most neurodegenerative diseases such as Alzheimer’s disease, type 2 diabetes, Parkinson’s disease, etc. are caused by inclusions and plaques containing misfolded protein aggregates.
Sushma Subedi   +4 more
doaj   +1 more source

Aggregation of an Amyloidogenic Peptide on Gold Surfaces

open access: yesBiomolecules, 2023
Solid surfaces have been shown to affect the aggregation and assembly of many biomolecular systems. One important example is the formation of protein fibrils, which can occur on a range of biological and synthetic surfaces.
David L. Cheung
doaj   +1 more source

Selective inhibition of aggregation/fibrillation of bovine serum albumin by osmolytes: Mechanistic and energetics insights. [PDF]

open access: yesPLoS ONE, 2017
Bovine serum albumin (BSA) is an important transport protein of the blood and its aggregation/fibrillation would adversely affect its transport ability leading to metabolic disorder.
Moumita Dasgupta, Nand Kishore
doaj   +1 more source

Nontoxic Black Phosphorus Quantum Dots Inhibit Insulin Amyloid Fibrillation at an Ultralow Concentration

open access: yesiScience, 2020
Summary: Amyloid are protein aggregates formed by cross β structures assemblies. Inhibiting amyloid aggregation or facilitating its disassembly are considered to be two major effective therapeutic strategies in diseases involving peptide or protein ...
Siqi Wang   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy